GEODE CAPITAL MANAGEMENT, LLC - IMMUNOCELLULAR THERAPEUTICS ownership

Back to all holdings Add to watchlist

IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 16 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q4 2017$3,000
-25.0%
10,9950.0%0.00%–
Q3 2017$4,000
-55.6%
10,9950.0%0.00%–
Q2 2017$9,000
-73.5%
10,9950.0%0.00%–
Q1 2017$34,000
+54.5%
10,9950.0%0.00%–
Q4 2016$22,000–10,995–0.00%–
 Download
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q2 2017
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 276,530$5,0000.00%
IFP Advisors, Inc 95$00.00%
Certified Advisory Corp 20$00.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders